Replimune Group, Inc. (REPL) insider trading.
In Q3 2026, insiders at Replimune Group, Inc. reported 6 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $1.0M.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -79,124
- Insiders
- 5
- Last filed
- 2026-08-24
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Hill Emily Luisa | Officer · Chief Financial Officer | 2 | 0 | 2 |
| Astley-Sparke Philip | Director | 1 | 0 | 0 |
| Schwendenman Andrew | Officer · Chief Accounting Officer | 1 | 0 | 1 |
| Xynos Konstantinos | Officer · Chief Medical Officer | 1 | 0 | 1 |
| Patel Sushil | Director, Officer · Chief Executive Officer | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-20 | Astley-Sparke Philip | G (D) | 50,000 | $0 | 1,362,414 | Form 4 |
| 2026-08-17 | Hill Emily Luisa | S (D) | 9,256 | $14.28 | 215,852 | Form 4 |
| 2026-08-10 | Schwendenman Andrew | S (D) | 7,632 | $12.97 | 99,425 | Form 4 |
| 2026-08-10 | Xynos Konstantinos | S (D) | 11,447 | $12.97 | 224,215 | Form 4 |
| 2026-08-10 | Hill Emily Luisa | S (D) | 11,448 | $12.97 | 225,108 | Form 4 |
| 2026-08-10 | Patel Sushil | S (D) | 39,341 | $12.97 | 708,151 | Form 4 |
Transaction codes in this quarter
Get REPL insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1737953&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · REPL company page · Replimune Group, Inc. on SEC.gov
Questions
Are insiders buying or selling Replimune Group, Inc. (REPL)?
In Q3 2026, insiders at Replimune Group, Inc. reported 6 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $1.0M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Replimune Group, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/repl.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.